Major Christopher D, Santulli Rosemary J, Derian Claudia K, Andrade-Gordon Patricia
Johnson & Johnson Pharmaceutical Research and Development, L.L.C., Spring House, PA 19477-0776, USA.
Arterioscler Thromb Vasc Biol. 2003 Jun 1;23(6):931-9. doi: 10.1161/01.ATV.0000070100.47907.26. Epub 2003 Apr 3.
It is well appreciated that thrombin as well as other proteases can act as signaling molecules that specifically regulate cells by cleaving and activating members of a novel class of protease-activated receptors (PARs). The utility of gene knockout strategies to define and better comprehend the physiological role of specific proteins is perhaps best exemplified in the field of thrombin receptors. The development of PAR knockout mice has provided the unique opportunity to identify and characterize new members of this novel family of GPCRs, evaluate the interaction of PARs jointly expressed in common cells and tissues, and better understand the role of PARs in thrombosis, restenosis, vascular remodeling, angiogenesis, and inflammation. Presently, 4 members of the PAR family have been cloned and identified. In this review, we examine experimental evidence gleaned from PAR-/- mouse models as well as how the use of PAR-/- mice has provided insights toward understanding the physiological role of thrombin in cells of the vascular system and vascular pathology.
众所周知,凝血酶以及其他蛋白酶可作为信号分子,通过切割并激活一类新型蛋白酶激活受体(PARs)的成员来特异性调节细胞。基因敲除策略在定义和更好理解特定蛋白质的生理作用方面的效用,在凝血酶受体领域或许得到了最佳体现。PAR基因敲除小鼠的培育提供了独特的机会,可用于识别和表征这个新型GPCR家族的新成员,评估共同表达于普通细胞和组织中的PARs之间的相互作用,并更好地理解PARs在血栓形成、再狭窄、血管重塑、血管生成和炎症中的作用。目前,PAR家族的4个成员已被克隆和鉴定。在这篇综述中,我们审视了从PAR-/-小鼠模型中收集到的实验证据,以及使用PAR-/-小鼠如何为理解凝血酶在血管系统细胞中的生理作用和血管病理学提供了见解。